FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Monique den Brok

Research Profile

Chemicals & Drugs

Concepts & Ideas

Procedures

Occupations

Phenomena

Drug Contamination

Co-author Network

Publications

TOP 3
Monique W J den Brok; Bastiaan Nuijen; J L García; Elena Miranda; P Calvo; Consuelo Manada; Jos H Beijnen
Compatibility and stability of the novel anticancer agent ES-285 x HCl formulated with 2-hydroxypropyl-beta-cyclodextrin in infusion devices.
Monique W J den Brok; Bastiaan Nuijen; J Jantina Kettenes-van den Bosch; Mies J van Steenbergen; Josie N Buluran; Michael D Harvey; Charles K Grieshaber; Jos H Beijnen
Pharmaceutical development of a parenteral lyophilised dosage form for the novel anticancer agent C1311.
Monique W J den Brok; Bastiaan Nuijen; Michel J X Hillebrand; Charles K Grieshaber; Michael D Harvey; Jos H Beijnen
Development and validation of an LC-UV method for the quantification and purity determination of the novel anticancer agent C1311 and its pharmaceutical dosage form.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Monique den Brok (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2006: Monique W J den Brok; Bastiaan Nuijen; J L García; Elena Miranda; P Calvo; Consuelo Manada; Jos H Beijnen
Compatibility and stability of the novel anticancer agent ES-285 x HCl formulated with 2-hydroxypropyl-beta-cyclodextrin in infusion devices.
Die Pharmazie 2006;61(1):21-4.
2005: Monique W J den Brok; Bastiaan Nuijen; J Jantina Kettenes-van den Bosch; Mies J van Steenbergen; Josie N Buluran; Michael D Harvey; Charles K Grieshaber; Jos H Beijnen
Pharmaceutical development of a parenteral lyophilised dosage form for the novel anticancer agent C1311.
PDA journal of pharmaceutical science and technology / PDA 2005;59(5):285-97.
2005: Monique W J den Brok; Bastiaan Nuijen; Michel J X Hillebrand; Charles K Grieshaber; Michael D Harvey; Jos H Beijnen
Development and validation of an LC-UV method for the quantification and purity determination of the novel anticancer agent C1311 and its pharmaceutical dosage form.
Journal of pharmaceutical and biomedical analysis 2005;39(1-2):46-53.
2005: Monique W J den Brok; Bastiaan Nuijen; Eric E Challa; Christian Lutz; Hans-Georg Opitz; Jos H Beijnen
Compatibility and stability of Imexon in infusion devices and its in vitro biocompatibility.
Anti-cancer drugs 2005;16(7):727-32.
2005: Monique W J den Brok; Bastiaan Nuijen; Michel J X Hillebrand; Christian Lutz; Hans-Georg Opitz; Jos H Beijnen
LC-UV method development and validation for the investigational anticancer agent imexon and identification of its degradation products.
Journal of pharmaceutical and biomedical analysis 2005;38(4):686-94.
2005: Monique W J den Brok; Bastiaan Nuijen; Dieuwke M Meijer; Elena Millán; Consuelo Manada; Jos H Beijnen
Pharmaceutical development of a parenteral lyophilised formulation of the investigational anticancer agent ES-285.HCl.
PDA journal of pharmaceutical science and technology / PDA 2005;59(4):246-57.
2005: Monique W J den Brok; Bastiaan Nuijen; Christian Lutz; Hans-Georg Opitz; Jos H Beijnen
Pharmaceutical development of a lyophilised dosage form for the investigational anticancer agent Imexon using dimethyl sulfoxide as solubilising and stabilising agent.
Journal of pharmaceutical sciences 2005;94(5):1101-14.
2005: Monique W J den Brok; Bastiaan Nuijen; Remko Harms; Josie N Buluran; Michael D Harvey; Charles K Grieshaber; Jos H Beijnen
Compatibility and stability of the novel anti-cancer agent C1311 in infusion devices and its in vitro biocompatibility.
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners 2005;11(1):13-9.
2004: Monique W J den Brok; Sabien C van der Schoot; Bastiaan Nuijen; Michel J X Hillebrand; Jos H Beijnen
2-Hydroxypropyl-beta-cyclodextrin extracts 2-phenylphenol from silicone tubing.
International journal of pharmaceutics 2004;278(2):303-9.
2003: Monique W J den Brok; Bastiaan Nuijen; Elena Miranda; Pablo Floriano; Simon Munt; Ignacio Manzanares; Jos H Beijnen
Development and validation of a liquid chromatography-ultraviolet absorbance detection assay using derivatisation for the novel marine anticancer agent ES-285 x HCl [(2S,3R)-2-amino-3-octadecanol hydrochloride] and its pharmaceutical dosage form.
Journal of chromatography. A 2003;1020(2):251-8.